Skip to main content
SpringerLink
Log in

Congenital heart defects following in utero SSRI exposure

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Nembhard WN, et al. Maternal and infant genetic variants, maternal periconceptional use of selective serotonin reuptake inhibitors, and risk of congenital heart defects in offspring: population based study. BMJ 356: j832, 6 Mar 2017. Available from: URL: https://doi.org/10.1136/bmj.j832

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Congenital heart defects following in utero SSRI exposure. Reactions Weekly 1643, 6 (2017). https://doi.org/10.1007/s40278-017-27479-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-017-27479-6

Search

Navigation